Keywords

#satralizumab

Satralizumab

Monoclonal antibody

Satralizumab, sold under the brand name Enspryng, is a humanized monoclonal antibody medication that is used for the treatment of neuromyelitis optica spectrum disorder (NMOSD), a rare autoimmune disease. The drug is being developed by Chugai Pharmaceutical, a subsidiary of Roche.

Sat 7th

Provided by Wikipedia

Learn More

This keyword could refer to multiple things. Here are some suggestions:

Satralizumab Avacincaptad pegol Neuromyelitis optica spectrum disorder Chugai Pharmaceutical Co. Theralizumab List of therapeutic monoclonal antibodies ATC code L04 List of drugs granted breakthrough therapy designation Outline of immunology Spartalizumab
0 searches
This keyword has never been searched before
This keyword has never been searched for with any other keyword.